Polar Capital Holdings’s Akoya BioSciences AKYA Stock Holding History

Polar Capital Holdings’s Portfolio AKYA Stock Details AKYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-329,756	Closed	-$772K	–	290
2024 Q2	$772K	Sell	329,756 -1,250,000	-79%	-$3.99M	﹤0.01%	258
2024 Q1	$7.41M	Hold	1,579,756	–	–	0.04%	219
2023 Q4	$7.71M	Hold	1,579,756	–	–	0.05%	217
2023 Q3	$7.35M	Buy	1,579,756 +64,286	+4%	+$369K	0.05%	208
2023 Q2	$11.2M	Buy	1,515,470 +200,000	+15%	+$1.34M	0.06%	187
2023 Q1	$10.8M	Hold	1,315,470	–	–	0.07%	183
2022 Q4	$12.6M	Hold	1,315,470	–	–	0.1%	175
2022 Q3	$15.5K	Hold	1,315,470	–	–	0.1%	159
2022 Q2	$16.9K	Hold	1,315,470	–	–	0.1%	159
2022 Q1	$14.5K	Hold	1,315,470	–	–	0.07%	199
2021 Q4	$20.1K	Buy	1,315,470 +250,000	+23%	+$3.27M	0.08%	170
2021 Q3	$14.9K	Buy	1,065,470 +815,470	+326%	+$13.6M	0.06%	194
2021 Q2	$4.83K	Buy	+250,000	New	+$5.16M	0.02%	282

Other funds holding AKYA

BWLSA

Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAPAIJV

Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

PCA

Peddock Capital Advisors Braintree, Massachusetts $501M AUM 29.8% 1-Year Est. Return

Polar Capital Holdings's AKYA Position: Q3 2024 in Review

Polar Capital Holdings sold out of Akoya BioSciences (AKYA) in Q3 2024, closing a stake of 329,756 shares — an estimated $772K sold.

Polar Capital Holdings first reported a position in AKYA in Q2 2021 and held it in 13 quarters. The position peaked at $12.6M in Q4 2022. 59 funds tracked by Wall St. Rank hold AKYA as of Q3 2024.

Polar Capital Holdings reported no remaining Akoya BioSciences position as of Q3 2024 after selling out during the quarter.
Polar Capital Holdings sold 329,756 Akoya BioSciences shares in Q3 2024, an estimated $772K.
Polar Capital Holdings first reported a position in Akoya BioSciences in Q2 2021 and held it in 13 quarters.
Polar Capital Holdings's Akoya BioSciences position peaked at $12.6M in Q4 2022.
59 funds tracked by Wall St. Rank held Akoya BioSciences as of Q3 2024.

Based on Polar Capital Holdings's 13F filing for Q3 2024, filed 14 Nov 2024.